Catalog No.
Product Name
Application
Product Information
Citations
-
Antiplatelet Aggregation Agent
Imolamine is a potent antiplatelet aggregation agent that functions through the modulation of platelet activation pathways. As a phenyl aminoxidiazole derivative, it demonstrates significant anti-thrombotic activity, making it a valuable tool for studying platelet biology and associated disorders. This compound is relevant for research into coronary heart disease and other cardiovascular conditions where platelet aggregation plays a critical role. -
α1 Adrenergic Receptor Agonist
Phenylephrine hydrochloride is an α1 adrenergic receptor agonist primarily used as a sympathomimetic agent. It induces vasoconstriction and increases perfusion pressure, making it valuable in clinical settings for managing hypotension and as a decongestant. Researchers utilize Phenylephrine hydrochloride to study cardiovascular responses and the pharmacological effects of adrenergic activation in various biological systems. -
Drug Intermediate
1-epi-Regadenoson ethyl ester is a key intermediate in the synthesis of the α-isomer impurity of Regadenoson, a highly selective agonist for the adenosine A2A receptor. This compound is essential for research involving adenosine receptor biology and contributes to the understanding of cardiovascular function and cellular signaling pathways. Its application extends to the development and analysis of therapeutic agents targeting adenosine receptors. -
Synthetic Cannabinoid
5-Fluoropentylindole serves as a synthetic cannabinoid that primarily targets cannabinoid receptors in the central nervous system. This compound exhibits significant affinity for CB1 receptors, making it a valuable tool for studying the endocannabinoid system and its associated signaling pathways. 5-Fluoropentylindole is applicable in pharmacological research and may aid in investigating the effects of synthetic cannabinoids on physiological processes and potential therapeutic outcomes. -
Drug Intermediate
1-epi-Regadenoson hydrazone serves as a crucial intermediate in the synthesis of the α-isomer impurity of Regadenoson, a selective adenosine A2A receptor agonist. Its role in the development of this compound is significant for research in cardiovascular pharmacology and adenosine receptor modulation. This reagent is essential for investigations into therapeutic applications targeting the A2A receptor pathway. -
Drug Impurity
Mirabegron impurity 10 is a known impurity associated with the pharmacological agent Mirabegron, a selective beta-3 adrenergic receptor agonist. It is crucial for studies focused on drug purity and stability, as well as for understanding the synthesis and degradation pathways of Mirabegron. This impurity serves as a reference standard for analytical methods and quality control processes in pharmaceutical development and research applications. -
Drug Impurity
Salbutamol impurity 7 is a known impurity of the bronchodilator Salbutamol, which primarily targets beta-2 adrenergic receptors. This compound is important for analytical research and quality control in pharmaceutical development to ensure the purity and safety of Salbutamol formulations. Its presence can influence pharmacokinetics and therapeutic efficacy, making it relevant for studies focused on drug metabolism and impurities. -
Drug Impurity
Paliperidone impurity 3 is a known impurity of the antipsychotic agent Paliperidone, which primarily targets dopamine receptors. This compound is utilized in pharmaceutical research for quality control and to assess the purity of Paliperidone formulations. It serves as a crucial reference standard in the development and validation of analytical methods, ensuring compliance with regulatory standards in drug production. -
Drug Intermediate
2,6-Dichloropurine is a pharmaceutical intermediate primarily utilized in the synthesis of various drug candidates. This compound plays a key role in the development of phosphodiesterase (PDE) inhibitors, human A3 adenosine receptor antagonists, and cyclin-dependent kinase (CDK) inhibitors. Its versatile chemical structure makes it a valuable reagent in biomedical research and pharmaceutical development. -
Drug Derivative
Methiomeprazine is a drug derivative primarily targeting the dopaminergic system. It exhibits significant antipsychotic and sedative properties, making it valuable in the treatment of various psychiatric disorders. Methiomeprazine is commonly used in research related to neuropharmacology and the exploration of dopamine receptor interactions. Its efficacy in managing behavioral symptoms also positions it as a candidate for studies on mental health therapies. -
Biochemical Assay Reagent Control
N-Formyl desloratadine is an inhibitor targeting the H1 histamine receptor, primarily utilized as a biochemical assay reagent control. This compound demonstrates significant antihistamine activity, making it an essential tool for research related to allergic responses and histamine receptor activity. Its use in pharmacological studies allows for the assessment of H1 receptor modulation and the investigation of allergic conditions. -
Biochemical Assay Reagent
Duoperone is a neuroleptic agent that acts primarily by antagonizing dopamine receptors. This compound exhibits significant antiemetic properties in various animal models, making it valuable for studies related to nausea and psychotic disorders. Its applications extend to biochemical assays that investigate neurotransmitter dynamics and the pharmacological evaluation of antipsychotic drugs. -
Biochemical Assay Reagent Control
Clenhexerol is a selective beta-adrenergic agonist that primarily targets beta-2 adrenergic receptors. This compound exhibits biological activity by stimulating smooth muscle relaxation and inducing bronchodilation. It is commonly used as a biochemical assay reagent control in research focused on respiratory diseases, pharmacological studies, and the exploration of adrenergic signaling pathways. -
Ester Product
(9Z,11E)-Octadecadien ethanolamide is an ester product that serves as a bioactive lipid mediator. It is known to modulate endocannabinoid receptor activity and influences various physiological processes, including pain perception and inflammation. This compound is primarily utilized in research focused on lipid signaling pathways, cannabinoid receptor studies, and neurobiology. -
Biochemical Assay Reagent
NBD AEA is a fluorescent derivative of anandamide (arachidonoylethanolamide) designed for use as a biochemical assay reagent. This compound serves as a valuable tool for studying cannabinoid receptors and endocannabinoid signaling pathways. It enables the visualization and quantification of AEA interactions in various biological systems, facilitating research in pharmacology and neurobiology. -
Drug Impurity
Mirabegron impurity 6 is a recognized impurity of the pharmaceutical compound Mirabegron, which primarily acts as a β3-adrenergic receptor agonist. It serves as an important reference standard for quality control in the synthesis and analysis of Mirabegron and is crucial in ensuring the purity and efficacy of the drug. This impurity can assist in research applications involving pharmacokinetics, safety assessments, and metabolic studies of β3-adrenergic modulators. -
Drug Impurity
Tamsulosin impurity 15 is a chemical impurity associated with the pharmaceutical compound Tamsulosin, which primarily targets alpha-1 adrenergic receptors. This impurity is relevant for quality control and characterization in the development and analysis of Tamsulosin formulations. Research applications include assessing the purity and safety profiles of Tamsulosin in pharmaceutical formulations. -
Drug Impurity
(S)-Tamsulosin hydrochloride is a chiral impurity associated with the pharmaceutical compound tamsulosin, primarily targeting alpha-1 adrenergic receptors. This reagent may serve a critical role in the analytical characterization and quality control of tamsulosin formulations. Its presence can impact the pharmacological profile and efficacy of the drug, making it an essential component for research and development in pharmaceutical sciences. -
Drug Impurity
Acebutolol impurity 7 is a secondary compound generated during the synthesis of Acebutolol, a selective beta-1 adrenergic receptor blocker. This reagent is primarily utilized in drug development and quality control to ensure the purity and safety of pharmaceutical formulations. Its characterization and analysis are essential for compliance with regulatory standards in chemical research and formulation studies. -
Drug Impurity
Dexmedetomidine impurity 2 is a chemical impurity related to Dexmedetomidine, a selective alpha-2 adrenergic receptor agonist. This impurity is significant in assessing the purity and quality of Dexmedetomidine formulations. It is utilized primarily in analytical chemistry and pharmaceutical development, particularly for the evaluation of drug substances and ensuring compliance with regulatory standards. -
Drug Impurity
Pramipexole impurity 1 (2-N-Propyl pramipexole) is a chemical impurity associated with the drug Pramipexole, which targets dopamine receptors. This impurity is essential for quality control and validation studies in pharmaceutical research, ensuring the purity and safety of drug formulations. It serves as a reference compound in analytical chemistry and can facilitate the investigation of drug metabolism and pharmacokinetics. -
Drug Impurity
Ropinirole impurity 2 is a chemical impurity associated with the synthesis of Ropinirole, a dopamine receptor agonist. This compound can be utilized for analytical purposes in the assessment of drug purity and quality control in pharmaceutical research. Its presence is significant for the evaluation of Ropinirole formulations and may impact the overall efficacy and safety profile of the drug. -
Drug Impurity
Alfuzosin EP impurity 1 hydrochloride, also known as 2,3,4,5-Tetradehydro alfuzosin hydrochloride, is a recognized impurity of Alfuzosin hydrochloride. This compound is essential for evaluating the purity and stability of alfuzosin formulations in pharmaceutical development. Researchers may utilize this impurity in studies assessing drug quality, pharmacokinetics, and mechanism of action related to alpha-1 adrenergic receptor antagonism. -
Drug Derivative
SKF 83692 is a potent derivative that primarily targets dopamine receptors, specifically D1-like receptors. This compound exhibits notable biological activity in modulating dopaminergic signaling, making it valuable for research in neuropharmacology and the study of dopamine-related disorders. SKF 83692 serves as an important tool for investigating receptor pharmacology and the potential therapeutic effects of dopamine modulation in various neurological conditions. -
Propranolol Analogue
KP-19 is a Propranolol analogue that targets β-adrenergic receptors, influencing cardiac function and stress response. This compound exhibits potential biological activity in modulating cardiovascular mechanisms and offers insights into the treatment of cardiovascular diseases. Its application in research may contribute to understanding therapeutic strategies for managing heart-related conditions. -
Benzofuran
5-EAPB hydrochloride is a benzofuran derivative that acts primarily as a serotonin and dopamine receptor modulator. This compound is known for its psychoactive properties and has been used in neurological research to explore the mechanisms of mood regulation and cognitive function. Its ability to enhance serotonergic transmission makes it a valuable tool for studying various neuropharmacological applications. -
Intermediate
4-Propionamidophenol is an important intermediate in the synthesis of alkanolamine derivatives, primarily targeting β-adrenergic receptors. This compound exhibits significant β-adrenergic blocking activity, making it useful for research into cardiovascular conditions, including heart disease and hypertension. Its utility in synthesizing related compounds enhances its potential for various pharmacological studies. -
Phytocannabinoid
Δ9-Tetrahydrocannabivarinic acid (THCVA) is a phytocannabinoid that acts primarily on cannabinoid receptors, influencing various physiological processes. It exhibits potential anti-inflammatory properties and may play a role in modulating appetite and pain perception. THCVA is of interest in research relating to the therapeutic applications of cannabinoids in treating metabolic disorders and neurological conditions. -
Semaglutide Prodrug
Semaglutide Main Chain (9-37) serves as a peptide starting material for the synthesis of the semaglutide prodrug. This compound is integral in facilitating the development of semaglutide, which is a GLP-1 receptor agonist known for its role in enhancing glucose-dependent insulin secretion and reducing appetite. It is widely applicable in diabetes research and therapeutic development aimed at metabolic disorders. -
Somatostatin Analogue
DOTAMTATE is a somatostatin analogue that selectively targets somatostatin receptors. It exhibits significant potential for the imaging and treatment of somatostatin receptor-positive neuroendocrine tumors, making it a valuable tool for investigative research in oncology and radiopharmaceutical applications. The incorporation of 212Pb into DOTAMTATE enhances its therapeutic efficacy and suitability for targeted radionuclide therapy. -
Tetrahydrocannabinol Derivative
Δ9-THC-Ethyl is a derivative of Tetrahydrocannabinol (THC) featuring an ethyl chain modification. This compound primarily targets cannabinoid receptors and exhibits significant psychoactive properties. It is used in research to explore the pharmacological effects of cannabinoids, their therapeutic potential, and to study their role in various physiological processes. -
AEA Prodrug Analog
R-1 Methanandamide Phosphate is a water-soluble prodrug analog of arachidonylethanolamide (AEA), which acts primarily on cannabinoid receptors. This compound exhibits biological activity by enhancing the effects of endocannabinoids, providing insights into cannabinoid signaling pathways. It is suitable for research applications involving the study of the endocannabinoid system and its role in various physiological processes. -
Drug Derivative
N-Acetyl-3,4-MDMC is a drug derivative structurally related to 3,4-methylenedioxymethcathinone. This compound has been investigated for its psychoactive properties and potential interactions with monoamine transporters, particularly serotonin and dopamine receptors. Research applications include studies on its effects on neural activity and behavioral responses in various models of neurotransmission. -
Active Molecule
WAY-604603 is an active molecule that functions primarily as an allosteric modulator of the cannabinoid receptor 1 (CB1). It has demonstrated potential in influencing appetite regulation and neuroprotection. This compound is utilized in research exploring the endocannabinoid system and its implications in metabolic disorders and CNS functions. -
Phytocannabinoids Derivative
Cannabigerol monomethyl ether is a monomethyl ether derivative of the phytocannabinoid, cannabigerol. It exhibits potential biological activity by modulating cannabinoid receptors, thereby influencing a variety of physiological processes. This compound is suitable for research applications focusing on the endocannabinoid system, pharmacological studies of cannabinoids, and elucidation of their therapeutic effects. -
5-HT Derivative
5-Propargyltryptamide (5-PT) is an alkyne-functionalized derivative of serotonin (5-HT), serving as a substrate for serotonylation in living cells. This reagent enables the conjugation of biotin, facilitating the identification of serotonylated proteins through copper-catalyzed click chemistry and mass spectrometry. 5-PT selectively labels and isolates serotonylated proteins in alveolar epithelial cells, making it a valuable tool for proteomic analysis in the study of bronchopulmonary dysplasia and related respiratory conditions. -
Drug Derivative
Indanazoline is a drug derivative that acts primarily as a selective vasoconstrictor. It exhibits significant vasoconstrictive activity through its interactions with adrenergic receptors, making it valuable in cardiovascular research. This compound can be utilized in studies focusing on blood pressure regulation and vascular dynamics, contributing to the understanding of hypertensive conditions and related pharmacological treatments. -
Drug Derivative
TA-993 is a drug derivative that enhances limb blood flow primarily through the modulation of the sympathetic nervous system, bypassing adrenergic receptors. This compound demonstrates a distinctive mechanism of action, potentially influencing heart rate through alternative pathways. TA-993 is valuable for research applications focused on understanding vascular dynamics and autonomic control in various physiological and pathological states. -
Active Molecule
WAY-271999 is an active molecule that serves as a potent antagonist of the cannabinoid receptor type 1 (CB1). It exhibits significant modulation of neuropsychiatric and metabolic processes, making it a valuable tool for research in obesity, addiction, and mood disorders. This compound is suitable for in vitro and in vivo studies aimed at elucidating the role of CB1 signaling in various physiological and pathological conditions. -
Drug Derivative
Benzoadenosine is a drug derivative that acts as an adenosine receptor modulator. It exhibits biological activities that may influence cellular signaling pathways involving adenosine, making it valuable for research in pharmacology and drug development. This compound can be utilized to investigate the role of adenosine-related mechanisms in various biological processes and disease states. -
Vasoconstrictor Agent
Nordefrin, a derivative of norepinephrine, functions primarily as a vasoconstrictor agent. It exerts its biological activity by stimulating adrenergic receptors, leading to increased vascular resistance and elevated blood pressure. This compound is commonly utilized in research investigations focused on cardiovascular physiology and pharmacology, particularly those exploring blood pressure regulation and vascular function. -
Platelet Aggregation Inhibitor
Ataprost is a potent platelet aggregation inhibitor that functions as an orally active analogue of Carboprostacyclin. This compound demonstrates 2.6 times greater efficacy than Carboprostacyclin in inhibiting ADP-induced platelet aggregation in vitro. Additionally, Ataprost has been shown to alleviate coronary spasm, making it relevant for research in cardiovascular diseases and platelet function studies. -
Guanfacine Derivative
Etiguanfacine is a derivative of Guanfacine that primarily targets alpha-2 adrenergic receptors. It exhibits potential for reducing gastrointestinal side effects commonly associated with Guanfacine, making it a valuable tool for research into improved therapeutic profiles. This compound can be utilized in studies involving hypertension and attention-deficit hyperactivity disorder (ADHD), as well as in evaluating receptor-mediated mechanisms in neuropharmacology. -
Drug Derivative
Fepradinol is a drug derivative that primarily acts as a selective modulator of adrenergic receptors. This compound exhibits significant biological activity in influencing cardiovascular responses and can be utilized in research focused on cardiovascular pharmacology. Its modulatory effects make it valuable for investigating the therapeutic potential in treating various cardiovascular disorders. -
Drug Derivative
Methoserpidine is a drug derivative that primarily functions as an antagonist of the alpha-adrenergic receptor. This compound exhibits significant biological activity in modulating cardiovascular responses and neurotransmitter release, making it useful for research in hypertension and other cardiovascular disorders. Its properties enable exploration of adrenergic signaling pathways and may provide insights into potential therapeutic strategies. -
Dexoxadrol Enantiomer
Levoxadrol is the active enantiomer of dexoxadrol, primarily targeting adrenergic receptors. This compound exhibits potent agonistic activity, making it valuable for research applications in cardiovascular and neuropharmacology studies. Its distinct biological properties facilitate investigations into adrenergic signaling pathways and their role in various physiological and pathological conditions. -
Cannabinoid Compound
Δ8-THCO (delta 8-tetrahydrocannabinol) is a cannabinoid compound derived from Cannabis sativa. This compound exhibits psychoactive properties akin to delta-9-THC, engaging with the CB1 cannabinoid receptor, which is implicated in various physiological processes such as appetite, pain sensation, and mood regulation. Δ8-THCO is utilized in research focused on understanding the effects of cannabinoids on the endocannabinoid system and exploring potential therapeutic applications in pain management and anxiety treatment. -
Peptide
Cionin is a disulfotyrosyl hybrid peptide derived from cholecystokinin and gastrin. It primarily targets cholecystokinin receptors, mediating various physiological functions such as gastric motility and enzyme secretion. This compound is utilized in research applications examining gastrointestinal physiology and the endocrine system. Its unique structure allows for the exploration of receptor interactions and signaling pathways in peptide studies. -
Nasal Vasoconstrictor
Tymazoline hydrochloride is an imidazoline derivative known for its nasal vasoconstrictor properties. It acts primarily on alpha-adrenergic receptors, leading to the reduction of nasal mucosal edema. This compound is valuable in research applications related to rhinitis and other conditions involving nasal congestion. -
Drug Derivative
MRS 2500 is a potent drug derivative that selectively targets adenosine A3 receptors. This compound exhibits significant effects on cellular signaling pathways, making it valuable for research involving inflammation and cancer biology. MRS 2500 can be utilized in studies aimed at understanding the role of adenosine receptors in various physiological and pathological processes.
